Journal articleJ Clin Invest2026
Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer.
- Journal
- J Clin Invest
- Published
- 2 December 2025
- Citations
- 3
- Type
- Article
- License
- cc by
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 6
- Project 3: Mechanisms and therapeutic targeting of NRAS in melanoma P01CA203657↗
- Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510↗
- SToP Cancer SPORE: Administrative Core A P50CA257911↗
- Biological Activity of Ras Oncogenes R01CA042978↗
- Targeting undruggable RAS for cancer treatment R35CA232113↗
- Identification of synthetic lethal interactors in pancreatic cancer U01CA199235↗